Unknown

Dataset Information

0

Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site.


ABSTRACT:

Background

Cervical cancer (CC) remains a leading cause of gynaecological cancer-related mortality with infection by human papilloma virus (HPV) being the most important risk factor. We analysed the association between different viral integration signatures, clinical parameters and outcome in pre-treated CCs.

Methods

Different integration signatures were identified using HPV double capture followed by next-generation sequencing (NGS) in 272 CC patients from the BioRAIDs study [NCT02428842]. Correlations between HPV integration signatures and clinical, biological and molecular features were assessed.

Results

Episomal HPV was much less frequent in CC as compared to anal carcinoma (p?300 different HPV-chromosomal junctions (inter- or intra-genic). The most frequent integration site in CC was in MACROD2 gene followed by MIPOL1/TTC6 and TP63. HPV integration signatures were not associated with histological subtype, FIGO staging, treatment or PFS. HPVs were more frequently episomal in PIK3CA mutated tumours (p?=?0.023). Viral integration type was dependent on HPV genotype (p?ConclusionsThis is to our knowledge the first study assessing the prognostic value of HPV integration in a prospectively annotated CC cohort, which detects a hotspot of HPV integration at MACROD2; involved in impaired PARP1 activity and chromosome instability.

SUBMITTER: Kamal M 

PROVIDER: S-EPMC7884736 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Background</h4>Cervical cancer (CC) remains a leading cause of gynaecological cancer-related mortality with infection by human papilloma virus (HPV) being the most important risk factor. We analysed the association between different viral integration signatures, clinical parameters and outcome in pre-treated CCs.<h4>Methods</h4>Different integration signatures were identified using HPV double capture followed by next-generation sequencing (NGS) in 272 CC patients from the BioRAIDs study [NCT  ...[more]

Similar Datasets

| S-EPMC3397968 | biostudies-literature
| S-EPMC5740806 | biostudies-literature
| S-EPMC6584928 | biostudies-literature
| 2077042 | ecrin-mdr-crc
| S-EPMC1891667 | biostudies-literature
| S-EPMC3384597 | biostudies-literature
| S-EPMC3341860 | biostudies-literature
| S-EPMC4705232 | biostudies-literature
| S-EPMC4704079 | biostudies-literature
| S-EPMC4398508 | biostudies-literature